Stock listing

Xetra:PKN Revvity, Inc. Aktie

German listing (Xetra) of Revvity, Inc. · home listing NYSE:RVTY

Follow Revvity, Inc. into a list and get an email when it puts out news.

Home listing price · NYSE:RVTY

$145.22 USD -7.21 (-4.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:RVTY

Past year +54.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$143.61 – $150.93 USDNov 20, 2026
Volume
1.66M sharesNov 20, 2026
Market cap
$16.21B USDAt the close on Nov 20, 2026 · price × 111.6M shares outstanding
52-week range
$81.22 – $171.74 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$283.0M USDMedian day 1.68M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Revvity, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:RVTY · Home$145.22 USD-7.21 (-4.7%)1,663,061$150.93$150.93$143.61$152.43Close on Nov 20, 2026
LSE:0KHE$146.38 USD-7.27 (-4.7%)194$150.00$151.03$145.30$153.65Close on Nov 20, 2026
Frankfurt:PKN€135.20 EUR-2.30 (-1.7%)—€133.40€135.20€133.40€137.50Close on Nov 20, 2026
B3:R1VT3431.08 BRL0.00 (0.0%)—31.0831.0831.0831.08Close on Nov 19, 2026
Dusseldorf:PKN€131.90 EUR-6.60 (-4.8%)—€136.40€136.70€131.90€138.50Close on Nov 20, 2026
Munich:PKN€138.30 EUR-1.45 (-1.0%)—€138.30€138.30€138.30€139.75Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:RVTY · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$145.22-7.21-4.7%$150.93$150.93$143.611,663,061
$152.43+4.64+3.1%$146.66$153.10$146.661,094,180
$147.79-1.06-0.7%$149.22$151.43$146.841,511,028
$148.85-5.54-3.6%$153.06$153.06$147.181,480,335
$154.39-2.63-1.7%$160.17$160.59$151.061,306,667
$157.02-1.23-0.8%$156.51$159.36$153.041,467,522
$158.25-0.85-0.5%$161.07$163.29$158.211,173,440
$159.10-1.62-1.0%$161.50$161.89$156.841,148,653
$160.72+5.61+3.6%$157.44$161.93$154.151,722,981
$155.11+4.28+2.8%$150.83$158.96$149.381,683,248
$150.83-8.60-5.4%$157.67$158.69$150.372,294,936
$159.43-4.05-2.5%$167.69$167.69$155.962,860,578
$163.48+11.88+7.8%$163.01$171.74$162.583,372,215
$151.60-5.40-3.4%$160.07$160.07$150.642,797,680
$157.00-8.78-5.3%$164.21$164.21$155.813,179,837
$165.78+0.45+0.3%$165.32$167.30$163.051,528,722
$165.33+3.47+2.1%$163.00$169.06$162.852,178,407
$161.86+1.47+0.9%$158.82$162.76$156.281,551,625
$160.39+1.62+1.0%$159.37$161.67$159.101,089,129
$158.77+1.41+0.9%$156.35$159.05$152.731,113,400
$157.36+0.75+0.5%$156.18$161.64$154.871,779,700
$156.61+0.60+0.4%$154.44$159.48$152.711,995,300
$156.01+5.07+3.4%$152.64$157.58$152.191,396,700
$150.94-1.70-1.1%$153.89$156.87$150.711,259,500
$152.64-2.07-1.3%$154.44$155.50$151.611,336,300
$154.71+2.59+1.7%$151.91$156.86$148.832,374,800
$152.12-2.96-1.9%$154.26$158.00$151.452,023,200
$155.08-0.53-0.3%$156.44$157.46$153.101,387,600
$155.61+1.43+0.9%$153.74$156.33$153.461,116,000
$154.18+2.02+1.3%$152.40$155.50$152.401,224,300
$152.16-1.44-0.9%$152.04$152.54$146.701,456,900
$153.60+0.30+0.2%$153.03$156.01$149.252,233,600
$153.30-4.06-2.6%$161.62$166.25$151.452,678,200
$157.36+5.83+3.8%$151.45$157.45$150.391,549,600
$151.53+2.47+1.7%$149.94$153.38$148.551,236,600
$149.06-3.83-2.5%$155.48$155.48$148.312,483,800
$152.89+0.12+0.1%$153.49$158.28$152.814,456,000
$152.77+1.75+1.2%$150.49$153.06$149.291,600,100
$151.02-0.09-0.1%$148.97$151.05$148.121,500,500
$151.11+0.43+0.3%$150.70$151.99$147.031,940,500
$150.68+8.57+6.0%$141.79$152.26$141.792,539,900
$142.11-1.20-0.8%$142.40$145.00$140.082,244,300
$143.31-0.28-0.2%$143.12$144.77$141.712,871,300
$143.59+0.14+0.1%$144.53$145.55$142.302,062,000
$143.45-3.28-2.2%$146.50$146.89$142.453,321,600
$146.73+1.00+0.7%$147.61$149.52$145.222,753,800
$145.73+5.54+4.0%$140.88$147.50$140.203,404,200
$140.19+11.70+9.1%$128.67$140.22$128.673,693,800
$128.49+4.18+3.4%$124.69$128.70$123.951,895,200
$124.31+3.37+2.8%$122.40$124.65$121.611,151,500
$120.94-2.91-2.3%$122.77$123.23$120.901,344,000
$123.85-3.23-2.5%$125.77$126.66$121.201,882,200
$127.08-3.14-2.4%$128.50$129.54$126.891,496,200
$130.22-0.41-0.3%$130.03$131.70$129.561,175,200
$130.63-0.31-0.2%$132.45$133.00$127.781,817,100
$130.94+4.35+3.4%$125.94$131.75$125.942,101,500
$126.59-2.08-1.6%$127.46$128.18$125.493,056,600
$128.67-0.13-0.1%$127.34$128.82$125.461,631,800
$128.80-0.91-0.7%$128.57$130.07$127.261,576,300
$129.71+3.36+2.7%$126.53$129.80$126.501,932,700
$126.35+1.51+1.2%$123.29$126.90$123.291,155,800
$124.84+1.84+1.5%$123.69$124.94$122.011,035,600
$123.00-1.75-1.4%$123.49$124.89$121.381,505,400
$124.75+0.62+0.5%$124.48$124.97$121.512,289,700
$124.13+4.68+3.9%$118.26$124.49$116.962,344,500

Splits

4 splits since 1980 · NYSE:RVTY · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
2-for-1Split
2-for-1Split
2-for-1Split
Ticker
Xetra:PKN
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Xetra
Currency
EUR

What changed lately

Latest news

All Revvity, Inc. news

Revvity, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
26 in the last 12 months · 47 in all · newest Nov 13, 2026 · oldest 2025
Calls
17 calls with a replay · 17 with a transcript · latest Nov 3, 2026
Decks
34 decks · latest Nov 13, 2026

Where Revvity, Inc. is listed

ListingExchangeCountryCurrency
NYSE:RVTY · Home listingNYSEUnited StatesUSD
gettex:PKNgettexGermanyEUR
Tradegate:PKNTradegateGermanyEUR
LS Exchange:850943LS ExchangeGermanyEUR
Lang & Schwarz:850943Lang & SchwarzGermanyEUR
Stuttgart:PKNStuttgartGermanyEUR
LSE:0KHELSEUnited KingdomUSD
Frankfurt:PKNFrankfurtGermanyEUR
B3:R1VT34B3BrazilBRL
BOATS:RVTYBOATSUnited StatesUSD
BMV:RVTYBMVMexicoMXN
Dusseldorf:PKNDusseldorfGermanyEUR
Munich:PKNMunichGermanyEUR
BIVA:RVTYBIVAMexicoMXN
Xetra:PKN · This pageXetraGermanyEUR

Valuation

P/E 64.0× against a median of 32.1×: 8th lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Oct 4, 2026 · price Nov 20, 2026

Enterprise value
$18.25B USD
P/E
64.0×
EV/sales
6.2×
EV/EBITDA
23.3×
Price/book
2.2×
Gross margin
53.1%
Operating margin
12.7%
Net margin
8.6%
Debt to equity
0.4×
Beta vs S&P 500
1.12

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Revvity, Inc. · NYSE:RVTYUS$16.21BUS$18.25B64.0×6.2×23.3×2.2×8.6%0.4×1.12
Wuxi Biologics (Cayman) Inc. · HKEX:2269US$21.51BUS$19.96B29.2×6.1×15.9×3.0×22.5%0.1×n/a
Guardant Health, Inc. · NASDAQ:GHUS$19.73BUS$20.20Bn/a15.8×n/an/a−37.9%n/a1.16
Medpace Holdings, Inc. · NASDAQ:MEDPUS$17.08BUS$16.37B33.0×5.8×25.8×29.2×18.2%0.0×0.72
Charles River Laboratories International, Inc. · NYSE:CRLUS$15.06BUS$14.86B375×3.7×33.5×4.7×1.0%0.0×1.23
ICON plc · NASDAQ:ICLRUS$14.41BUS$16.98B32.1×2.1×15.7×1.6×5.5%0.4×1.08
bioMerieux SA · EURONEXT:BIMUS$11.79BUS$11.53B27.0×2.6×10.9×2.5×9.8%0.1×n/a
Bio-Techne Corp · NASDAQ:TECHUS$11.41BUS$11.35B66.4×9.2×33.6×5.3×14.0%0.1×0.54
Qiagen N.V. · NYSE:QGENUS$10.18BUS$11.03B24.9×5.3×15.0×3.0×19.5%0.5×0.33
Avantor, Inc. · NYSE:AVTRUS$10.06BUS$13.28B29.8×2.0×14.7×1.7×5.1%0.6×0.78
WuXi XDC Cayman, Inc. · HKEX:2268US$9.64BUS$8.87B43.4×9.9×33.4×5.7×24.9%0.1×n/a
Median of the othersUS$13.10BUS$14.07B32.1×5.5×15.9×3.0×11.9%0.1×0.78

Forecasts

6 strong buy · 11 hold · 1 sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
171.40 USD · Analysts' mean
EPS, year to Dec 2026
5.44 · 17 analysts
Revenue, year to Dec 2026
2.87B · 17 analysts

Team and board

Officers

OfficerRole
Gene LaySenior Vice President, Life Sciences and CEO Advisor
Michelle McMurry-HeathFounder and Chief Executive Officer, BioTechquity Clinical
Prahlad R. SinghPresident and Chief Executive Officer, Revvity
Max KrakowiakSenior Vice President and Chief Financial Officer
Kevin WilloePresident, Revvity Signals Software
Michael A. KlobucharChief Operating Officer, Eikon Therapeutics, Inc.
Joel GoldbergSenior Vice President, Administration, General Counsel and Secretary
Steve WilloughbyInvestor Relations
Arvind Sundar-RajanSenior Vice President, Chief Digital & Strategy Officer
Bryan KippSenior Vice President, Technology and Licensing
Craig MonellSenior Vice President, Reagents
Kevin QuickVice President of Platforms
Madhuri HegdeSenior Vice President and Chief Scientific Officer
Magali FourSenior Vice President, Chief People and Culture Officer
Miriame VictorSenior Vice President and Chief Business Officer
Tajinder VohraSenior Vice President, Global Operations
Yi-Ping LinSenior Vice President, Chief Quality, Regulatory and Clinical Officer
Yves DubaquieSenior Vice President, Diagnostics

Board

DirectorRole
Alexis P. MichasManaging Partner, Juniper Investment Company, LLC - Non-Executive Chair
Frank WitneyDirector
Michael A. KlobucharChief Operating Officer, Eikon Therapeutics, Inc.
Michel VounatsosDirector
Michelle McMurry-HeathFounder and Chief Executive Officer, BioTechquity Clinical
Pascale WitzDirector
Peter BarrettPartner, Atlas Venture
Prahlad R. SinghPresident and Chief Executive Officer, Revvity
Samuel R. ChapinDirector
Sophie V. VandebroekDirector

Events

Calls

CallWhenStatus
Revvity (NYSE:RVTY) Q3 2026 Earnings CallTue, Nov 03, 2026 · 7:30 AM ETReplay
Revvity (NYSE:RVTY) Q2 2026 Earnings CallTue, Aug 04, 2026 · 7:30 AM ETReplay
Revvity (NYSE:RVTY) Q1 2026 Earnings CallTue, May 05, 2026 · 7:30 AM ETReplay
Revvity (NYSE:RVTY) Q4 2025 Earnings CallMon, Feb 02, 2026 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q3 2025 Earnings CallMon, Oct 27, 2025 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q2 2025 Earnings CallMon, Jul 28, 2025 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q1 2025 Earnings CallMon, Apr 28, 2025 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q4 2024 Earnings CallFri, Jan 31, 2025 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q3 2024 Earnings CallMon, Nov 04, 2024 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q2 2024 Earnings CallMon, Jul 29, 2024 · 8:00 AM ETReplay
All 17 calls
CallWhenStatus
Revvity (NYSE:RVTY) Q1 2024 Earnings CallMon, Apr 29, 2024 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q4 2023 Earnings CallThu, Feb 01, 2024 · 8:00 AM ETReplay
Revvity (NYSE:RVTY) Q3 2023 Earnings CallMon, Oct 30, 2023 · 8:00 AM ETReplay
PerkinElmer, Inc. (PKI) Q4 2022 Earnings CallTue, Feb 14, 2023 · 8:00 AM ETReplay
PerkinElmer, Inc. (PKI) Q3 2022 Earnings CallTue, Nov 08, 2022 · 8:00 AM ETReplay
PerkinElmer, Inc. (PKI) Q2 2022 Earnings CallMon, Aug 01, 2022 · 8:00 AM ETReplay
PerkinElmer, Inc. (PKI) Q1 2022 Earnings CallTue, May 03, 2022 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 3, 2026 · Before open+7.8%
Q2 2026Aug 4, 2026 · Before open−3.3%
Q1 2026May 5, 2026 · Before open+6.7%
Q4 2025Feb 2, 2026 · Before open−1.6%
Q3 2025Oct 27, 2025 · Before open−1.8%
Q2 2025Jul 28, 2025 · Before open−8.3%
Q1 2025Apr 28, 2025 · Before open+0.8%
Q4 2024Jan 31, 2025 · Before open−0.6%
Q3 2024Nov 4, 2024 · Before open+3.1%
Q2 2024Jul 29, 2024 · Before open+9.1%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 29, 2024 · Before open+3.5%
Q4 2023Feb 1, 2024 · Before open+1.9%
Q3 2023Oct 30, 2023 · Before open−16.1%
Q2 2023Aug 1, 2023 · Before open−0.3%
Q1 2023May 11, 2023 · Before open−5.0%
Q4 2022Feb 14, 2023 · Before open−0.5%
Q3 2022Nov 8, 2022 · Before open−1.6%
Q2 2022Aug 1, 2022 · Before open+5.0%
Q1 2022May 3, 2022 · After close+2.8%
Q4 2021Feb 1, 2022 · After close+6.2%

Open Events

Decks

DeckKindSlidesDate
Investor Day (November 2026)Investor day91 slidesNov 13, 2026
Q3 2026 Earnings PresentationEarnings9 slidesNov 3, 2026
Q2 2026 Earnings PresentationEarnings9 slidesAug 4, 2026
Q1 2026 Earnings PresentationEarnings9 slidesMay 5, 2026
Q1 2026 Earnings PresentationEarnings109 slidesMay 5, 2026
Q4 2025 Earnings PresentationEarnings11 slidesFeb 2, 2026
J.P. Morgan 44th Healthcare Conference (January 2026)Conference20 slidesJan 13, 2026
Q3 2025 Earnings PresentationEarnings9 slidesOct 27, 2025
Q2 2025 Earnings PresentationEarnings9 slidesJul 28, 2025
Q1 2025 Earnings PresentationEarnings9 slidesApr 28, 2025
All 34 decks
DeckKindSlidesDate
Q4 2024 Earnings PresentationEarnings11 slidesJan 31, 2025
J.P. Morgan Healthcare Conference 2025Conference21 slidesJan 13, 2025
Q3 2024 Earnings PresentationEarnings9 slidesNov 4, 2024
Q2 2024 Earnings PresentationEarnings9 slidesJul 29, 2024
Q1 2024 Earnings PresentationEarnings9 slidesApr 29, 2024
Q4 2023 Earnings PresentationEarnings11 slidesFeb 1, 2024
42nd J.P. Morgan Healthcare Conference 2024Conference17 slidesJan 9, 2024
Q3 2023 Earnings PresentationEarnings9 slidesOct 30, 2023
Q2 2023 Earnings PresentationEarnings9 slidesAug 1, 2023
Q1 2023 Earnings PresentationEarnings9 slidesMay 11, 2023
Fact Sheet (2023)Fact sheet2 slidesMay 9, 2023
Q4 2022 Earnings PresentationEarnings8 slidesFeb 14, 2023
J.P. Morgan 41st Healthcare Conference (January 2023)Conference31 slidesJan 10, 2023
PerkinElmer — Q3 2022 Earnings PresentationEarnings7 slidesNov 8, 2022
PerkinElmer — Q2 2022 Earnings PresentationEarnings7 slidesAug 1, 2022
PerkinElmer — Merger or Acquisition (August 2022)Merger or acquisition10 slidesAug 1, 2022
PerkinElmer — Q1 2022 Earnings PresentationEarnings7 slidesMay 3, 2022
Q4 2021 Earnings PresentationEarnings8 slidesFeb 1, 2022
PerkinElmer — J.P. Morgan Healthcare Conference 2022Conference35 slidesJan 11, 2022
PerkinElmer — Q3 2021 Earnings PresentationEarnings7 slidesNov 2, 2021
PerkinElmer — Q2 2021 Earnings PresentationEarnings7 slidesJul 26, 2021
PerkinElmer — Investor Day (June 2021)Investor day105 slidesJun 24, 2021
PerkinElmer — J.P. Morgan Healthcare Conference 2021Conference33 slidesJan 11, 2021
Perkinelmer — Merger or Acquisition (October 2005)Merger or acquisition9 slidesOct 7, 2005

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue2.86B2.76B2.75B3.31B3.83B3.78B2.88B2.78B2.26B2.12B
Cost of revenue1.34B1.43B1.43B1.55B1.55B1.79B1.59B1.44B708.7M664.8M
Gross profit1.52B1.32B1.32B1.99B2.43B2.11B1.40B1.34B1.07B1.01B
Research and development215.8M196.8M216.6M221.6M200.3M146.4M189.3M194.0M139.5M124.2M
Selling, general and administrative991.9M994.1M1.02B1.03B975.2M716.5M815.3M811.9M626.0M590.5M
Operating income356.6M346.7M300.6M742.7M1.26B867.3M362.0M323.9M295.6M294.6M
Depreciation and amortization405.3M427.8M431.8M427.0M311.4M201.6M214.0M180.6M105.0M100.0M
EBITDA762.0M774.6M732.3M1.17B1.57B1.07B576.0M504.5M400.6M394.6M
Interest expense92.2M96.3M98.8M104.0M102.1M49.7M63.6M67.0M43.9M41.5M
Income before tax268.3M316.1M183.0M651.8M1.20B800.1M237.1M257.7M296.7M244.1M
Income tax28.4M33.1M3.47M139.2M314.1M169.5M9.39M20.2M139.8M28.4M
Net income241.2M270.4M693.1M569.2M943.2M727.9M227.6M237.9M292.6M234.3M
Earnings per share, basic2.072.215.564.518.126.522.062.152.672.14
Earnings per share, diluted2.072.205.554.508.086.492.042.132.642.12

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents919.9M1.16B913.2M454.4M603.3M387.1M191.9M163.1M202.1M359.3M
Short-term investments0689.9M0
Receivables744.7M632.4M632.8M612.8M707.9M1.16B725.2M632.7M552.3M425.6M
Inventory379.5M367.6M428.1M405.5M425.9M514.6M356.9M338.3M351.7M246.8M
Current assets2.24B2.35B3.00B3.29B2.44B2.24B1.37B1.23B1.20B1.19B
Property, plant and equipment479.2M482.2M509.7M482.9M485.5M368.3M318.2M318.6M298.1M145.5M
Goodwill6.61B6.46B6.53B6.48B6.63B2.64B3.11B2.95B3.00B2.25B
Total assets12.2B12.4B13.6B14.1B15.0B7.96B6.54B5.98B6.09B4.28B
Accounts payable185.5M167.5M204.1M272.8M324.8M327.3M235.9M220.9M222.1M168.0M
Current liabilities1.33B653.1M1.45B1.54B1.21B1.65B762.8M771.6M950.9M603.4M
Long-term debt2.63B3.15B3.18B3.92B4.98B1.61B2.06B1.88B1.79B1.05B
Total debt3.24B3.17B3.93B4.43B5.03B2.01B2.07B1.89B2.01B1.05B
Total liabilities4.92B4.73B5.69B6.75B7.86B4.22B3.72B3.39B3.59B2.12B
Shareholders' equity7.25B7.67B7.87B7.38B7.14B3.74B2.81B2.58B2.50B2.15B
Shares outstanding112.3M120.6M123.4M126.3M126.2M112.1M111.1M110.4M110.4M109.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations582.9M628.3M91.3M679.8M1.41B892.2M363.5M311.0M288.5M350.6M
Capital spending-73.5M-86.6M-81.4M-85.6M-86.0M-63.6M-76.3M-93.3M-39.1M-31.7M
Free cash flow509.4M541.7M9.90M594.2M1.32B828.5M287.1M217.8M249.4M318.9M
Cash from investing-17.4M776.2M1.31B-132.9M-4.11B-504.5M-487.6M-159.9M-1.27B-83.9M
Cash from financing-857.5M-1.13B-947.1M-661.8M2.94B-202.9M-150.1M-179.2M782.2M-115.0M
Dividends paid-32.8M-34.5M-35.0M-35.3M-32.4M-31.2M-31.1M-31.0M-30.8M-30.8M
Share buybacks-820.8M-369.6M-388.9M-80.6M-73.1M-6.94M-6.31M-57.4M-3.83M-151.8M
Change in cash-243.4M250.1M443.6M-148.6M216.7M210.7M25.6M-36.1M-174.2M138.3M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
8-K · Current reportNov 13, 2026Current reportSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 3, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 7, 2026Big-stake noticeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
144 · Notice of proposed saleOct 1, 2026Other filingsSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
144 · Notice of proposed saleSep 21, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 18, 2026Insider tradeSEC
144 · Notice of proposed saleSep 16, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 8, 2026Big-stake noticeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
8-K · Current reportAug 4, 2026ResultsSEC
4 · Change in ownershipJul 22, 2026Insider tradeSEC
144 · Notice of proposed saleJul 20, 2026Other filingsSEC
25-NSEJul 20, 2026Other filingsSEC
11-K · Annual report of an employee planJun 23, 2026Annual reportSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
SD · Specialized disclosureJun 1, 2026ESG reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
8-K · Current reportMay 5, 2026ResultsSEC
8-K · Current reportMay 1, 2026Meeting outcomeSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
144 · Notice of proposed saleApr 20, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
ARS · Annual report to shareholdersMar 16, 2026Annual reportSEC
DEFA14A · Additional proxy materialMar 16, 2026Meeting noticeSEC
DEF 14A · Proxy statementMar 16, 2026Meeting noticeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
PRE 14A · Preliminary proxy statementMar 6, 2026Meeting noticeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
10-K · Annual reportFeb 24, 2026Annual reportSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 5, 2026Other filingsSEC
144 · Notice of proposed saleFeb 5, 2026Other filingsSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 2, 2026Other filingsSEC
8-K · Current reportFeb 2, 2026ResultsSEC
8-K · Current reportJan 13, 2026ResultsSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
4 · Change in ownershipOct 31, 2025Insider tradeSEC
8-K · Current reportOct 27, 2025ResultsSEC
8-K · Current reportOct 24, 2025Management or board changeSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
144 · Notice of proposed saleAug 27, 2025Other filingsSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportJul 28, 2025ResultsSEC
11-K · Annual report of an employee planJun 20, 2025Annual reportSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
144 · Notice of proposed saleMay 29, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
4 · Change in ownershipMay 1, 2025Insider tradeSEC
8-K · Current reportApr 28, 2025ResultsSEC
8-K · Current reportApr 25, 2025Meeting outcomeSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC
ARS · Annual report to shareholdersMar 12, 2025Annual reportSEC
DEFA14A · Additional proxy materialMar 12, 2025Meeting noticeSEC
DEF 14A · Proxy statementMar 12, 2025Meeting noticeSEC
S-3ASR · Registration statementFeb 28, 2025Offer documentSEC
PRE 14A · Preliminary proxy statementFeb 26, 2025Meeting noticeSEC
10-K · Annual reportFeb 25, 2025Annual reportSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 7, 2025Insider tradeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 6, 2025Other filingsSEC
4 · Change in ownershipJan 31, 2025Insider tradeSEC
8-K · Current reportJan 31, 2025ResultsSEC
144 · Notice of proposed saleJan 30, 2025Other filingsSEC
8-K · Current reportJan 13, 2025ResultsSEC
4 · Change in ownershipJan 8, 2025Insider tradeSEC
144 · Notice of proposed saleJan 7, 2025Other filingsSEC
8-K · Current reportJan 7, 2025Material contractSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
S-8 · Registration statement for employee plansDec 4, 2024Offer documentSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
144 · Notice of proposed saleDec 2, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
8-K · Current reportNov 4, 2024ResultsSEC
4 · Change in ownershipOct 10, 2024Insider tradeSEC
144 · Notice of proposed saleOct 9, 2024Other filingsSEC
4 · Change in ownershipOct 9, 2024Insider tradeSEC
144 · Notice of proposed saleOct 8, 2024Other filingsSEC
144/A · Notice of proposed sale, amendedOct 7, 2024Other filingsSEC
144 · Notice of proposed saleOct 7, 2024Other filingsSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
4 · Change in ownershipAug 16, 2024Insider tradeSEC
144 · Notice of proposed saleAug 15, 2024Other filingsSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
144/A · Notice of proposed sale, amendedAug 7, 2024Other filingsSEC
144 · Notice of proposed saleAug 7, 2024Other filingsSEC
10-Q · Quarterly reportAug 6, 2024Quarterly reportSEC
8-K · Current reportJul 29, 2024ResultsSEC
11-K · Annual report of an employee planJun 27, 2024Annual reportSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
144 · Notice of proposed saleJun 7, 2024Other filingsSEC
SD · Specialized disclosureMay 31, 2024ESG reportSEC
144 · Notice of proposed saleMay 15, 2024Other filingsSEC
10-Q · Quarterly reportMay 7, 2024Quarterly reportSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
8-K · Current reportApr 29, 2024ResultsSEC
8-K · Current reportApr 24, 2024Meeting outcomeSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 21, 2024Insider tradeSEC
ARS · Annual report to shareholdersMar 13, 2024Annual reportSEC
DEFA14A · Additional proxy materialMar 13, 2024Meeting noticeSEC
DEF 14A · Proxy statementMar 13, 2024Meeting noticeSEC
4 · Change in ownershipMar 1, 2024Insider tradeSEC
144 · Notice of proposed saleFeb 29, 2024Other filingsSEC
4 · Change in ownershipFeb 29, 2024Insider tradeSEC
144 · Notice of proposed saleFeb 27, 2024Other filingsSEC
10-K · Annual reportFeb 27, 2024Annual reportSEC
4 · Change in ownershipFeb 26, 2024Insider tradeSEC
4 · Change in ownershipFeb 26, 2024Insider tradeSEC
144 · Notice of proposed saleFeb 23, 2024Other filingsSEC
144 · Notice of proposed saleFeb 23, 2024Other filingsSEC
4 · Change in ownershipFeb 16, 2024Insider tradeSEC
4 · Change in ownershipFeb 16, 2024Insider tradeSEC
4 · Change in ownershipFeb 16, 2024Insider tradeSEC
4 · Change in ownershipFeb 16, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Revvity, Inc.’s releases · as of Nov 6, 2026

Common shares
111,638,757
Fully diluted
111,638,757

Fully diluted

LineSharesAs of
Common shares111,638,757Nov 6, 2026

Share count over time

CountShares
Nov 6, 2026111,638,757

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
T. Rowe Price21.8MUS$3.34BSep 30, 2026
Vanguard13.1MUS$2BSep 30, 2026
BlackRock7.78MUS$1.19BSep 30, 2026
Janus Henderson7.39MUS$1.13BSep 30, 2026
EdgePoint Investment Group Inc.5.33MUS$814MSep 30, 2026
State Street4.37MUS$668MSep 30, 2026
Dimensional3.41MUS$522MSep 30, 2026
Fidelity3.05MUS$466MSep 30, 2026
Geode Capital3.04MUS$464MSep 30, 2026
Morgan Stanley2.71MUS$414MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Victory Capital2.7MUS$412MSep 30, 2026
Allspring Global Investments Holdings, LLC2.25MUS$335MSep 30, 2026
Invesco2.19MUS$334MSep 30, 2026
Neuberger Berman Group LLC1.78MUS$272MSep 30, 2026
Durable Capital Partners LP1.32MUS$202MSep 30, 2026
UBS1.27MUS$194MSep 30, 2026
Pictet Asset Management Holding SA1.15MUS$175MSep 30, 2026
Schwab1.13MUS$173MSep 30, 2026
BNY1.08MUS$165MSep 30, 2026
Wellington1.08MUS$165MSep 30, 2026
Vaughan Nelson Investment Management, L.P.973KUS$149MSep 30, 2026
Jane Street960KUS$147MSep 30, 2026
Citadel920KUS$141MSep 30, 2026
Northern Trust919KUS$140MSep 30, 2026
Primecap Management Co821KUS$126MSep 30, 2026
Castle Hook Partners LP749KUS$115MSep 30, 2026
Bank of America691KUS$106MSep 30, 2026
Goldman Sachs624KUS$95.4MSep 30, 2026
Natixis Advisors, LLC606KUS$92.6MSep 30, 2026
BNP Paribas559KUS$85.5MSep 30, 2026
Woodline Partners LP537KUS$82.1MSep 30, 2026
Quantinno Capital Management LP509KUS$77.8MSep 30, 2026
Madison Asset Management, LLC490KUS$74.9MSep 30, 2026
Jones Financial Companies Lllp462KUS$69.7MSep 30, 2026
Eversept Partners, LP450KUS$68.8MSep 30, 2026
AllianceBernstein409KUS$62.5MSep 30, 2026
DWS385KUS$58.8MSep 30, 2026
Federated Hermes, Inc.382KUS$58.5MSep 30, 2026
Sei Investments Co367KUS$56.1MSep 30, 2026
JPMorgan352KUS$54.8MSep 30, 2026
Nuveen310KUS$47.3MSep 30, 2026
CIBC300KUS$45.8MSep 30, 2026
Legal & General294KUS$44.9MSep 30, 2026
Citigroup Inc276KUS$42.3MSep 30, 2026
Capital Group261KUS$39.8MSep 30, 2026
Millennium253KUS$38.7MSep 30, 2026
California Public Employees Retirement System244KUS$37.3MSep 30, 2026
Amundi243KUS$37.1MSep 30, 2026
Ameriprise231KUS$35.3MSep 30, 2026
Swiss National Bank226KUS$34.5MSep 30, 2026

This page holds 50 of 593 holders. Open Shareholders

Funds

HolderSharesValueAs of
T. Rowe Price Capital Appreciation Fund11.4MUS$1.27BJun 30, 2026
Janus Henderson Enterprise Fund5.75MUS$640MJun 30, 2026
Vanguard Total Stock Market Index Fund3.55MUS$394MJun 30, 2026
Vanguard 500 Index Fund2.89MUS$322MJun 30, 2026
Vanguard Small-Cap Index Fund2.56MUS$285MJun 30, 2026
JNL/T. Rowe Price Capital Appreciation Fund2.53MUS$282MJun 30, 2026
Victory Sycamore Established Value Fund2.37MUS$264MJun 30, 2026
T. Rowe Price Value Fund, Inc.2.16MUS$240MJun 30, 2026
Invesco S&P 500 Equal Weight ETF1.84MUS$207MJul 31, 2026
Allspring Special Mid Cap Value Fund1.75MUS$194MJun 30, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard Small-Cap Value Index Fund1.62MUS$180MJun 30, 2026
iShares Core S&P 500 ETF1.53MUS$171MJun 30, 2026
Fidelity 500 Index Fund1.45MUS$152MMay 31, 2026
Vy(R) T. Rowe Price Capital Appreciation Portfolio1.18MUS$131MJun 30, 2026
Neuberger Genesis Fund973KUS$102MMay 31, 2026
T. Rowe Price Capital Appreciation Equity ETF855KUS$95.1MJun 30, 2026
Penn Series Flexibly Managed Fund837KUS$93.1MJun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF788KUS$87.7MJun 30, 2026
Vanguard Capital Opportunity Fund660KUS$73.4MJun 30, 2026
U.S. Small Cap Value Portfolio612KUS$68.9MJul 31, 2026
Vanguard Institutional Index Fund607KUS$67.5MJun 30, 2026
Janus Henderson VIT Enterprise Portfolio483KUS$53.7MJun 30, 2026
U.S. Targeted Value Portfolio475KUS$53.5MJul 31, 2026
iShares Russell Mid-Cap ETF458KUS$51MJun 30, 2026
Dimensional U.S. Targeted Value ETF444KUS$50MJul 31, 2026
Fidelity Mid Cap Index Fund423KUS$47.6MJul 31, 2026
Calvert Equity Fund412KUS$45.8MJun 30, 2026
EQ/Janus Enterprise Portfolio388KUS$43.2MJun 30, 2026
Vaughan Nelson Small Cap Fund360KUS$40MJun 30, 2026
Vanguard Health Care Index Fund341KUS$35.6MMay 31, 2026
Dimensional US Small Cap Value ETF313KUS$35.2MJul 31, 2026
Janus Henderson Triton Fund309KUS$34.4MJun 30, 2026
Schwab U.S. Mid-Cap ETF306KUS$32MMay 31, 2026
JNL/T. Rowe Price Value Fund279KUS$31.1MJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF269KUS$29.9MJun 30, 2026
iShares Russell 1000 Value ETF250KUS$27.8MJun 30, 2026
Schwab S&P 500 Index Fund250KUS$28.1MJul 31, 2026
Madison Mid Cap Fund242KUS$27.2MJul 31, 2026
Dimensional U.S. Small Cap ETF242KUS$27.2MJul 31, 2026
Transamerica Janus Mid-Cap Growth VP241KUS$26.9MJun 30, 2026
Dimensional U.S. Core Equity 2 ETF238KUS$26.8MJul 31, 2026
Capital Appreciation Value Fund236KUS$24.7MMay 31, 2026
Small Cap Core Fund222KUS$25MJul 31, 2026
MidCap Value Fund I218KUS$24.5MJul 31, 2026
Fidelity Total Market Index Fund215KUS$22.5MMay 31, 2026
iShares S&P 500 Value ETF183KUS$20.4MJun 30, 2026
Fidelity Series Total Market Index Fund173KUS$18.1MMay 31, 2026
iShares Russell Mid-Cap Value ETF172KUS$19.1MJun 30, 2026
Bridge Builder Small/Mid Cap Value Fund159KUS$17.7MJun 30, 2026
AZL T Rowe Price Capital Appreciation Fund157KUS$17.4MJun 30, 2026

This page holds 50 of 491 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Gonzales Anita
Officer: VP and CAO
Sale84USD 155.48US$13,060Oct 1, 2026
Krakowiak Maxwell
Officer: Please See Remarks
Sale1,631USD 144.53US$236KSep 21, 2026
Vohra Tajinder S
Officer: Please See Remarks
Sale7,330USD 140.88US$1.03MSep 16, 2026
Gonzales Anita
Officer: Vice President and CAO
Sale85USD 109.48US$9,306Jul 20, 2026
Gonzales Anita
Officer: Vice President and CAO
Sale80USD 92.80US$7,424Apr 20, 2026

Big stakes

StakeStakeSharesDateFiling
T. Rowe Price Associates Inc11.80%13.2MSep 30, 2026Schedule 13G
T. Rowe Price Investment Management, Inc.9.20%10.3MAug 31, 2026Schedule 13G
Vanguard Capital Management LLC7.44%8.33MMar 31, 2026Schedule 13G
Janus Henderson Group PLC6.60%7.39MSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gregory L. Summe
Other companies: Wheels Up Experience Inc. (Director · Since at least Aug 7, 2024); GRAIL, Inc. (Director · Since at least Jun 21, 2024); Avantor, Inc. (Director · Since at least May 7, 2020); NXP Semiconductors N.V. (Director · Since at least Aug 1, 2019); Virgin Orbit Holdings Inc (Director · Apr 13, 2021 – Apr 13, 2021 · Past); NextGen Acquisition Corp. II (Director · Mar 22, 2021 – Mar 22, 2021 · Past); Xos, Inc. (Director · Oct 6, 2020 – Oct 6, 2020 · Past); Freescale Semiconductor Ltd (Director · Sep 5, 2014 – Dec 7, 2015 · Past); LMI Aerospace Inc (Director · Jul 21, 2014 – Jun 27, 2017 · Past); Automatic Data Processing, Inc. (Director · Sep 10, 2007 – Nov 25, 2013 · Past); State Street Corporation (Director · Apr 19, 2006 – Feb 18, 2025 · Past)
Exe. Chairman of the Board, Director · Jan 31, 2006 – Feb 27, 2009 · Past
Vicki Sato
Other companies: Allogene Therapeutics, Inc. (Director · Since at least Jul 30, 2021); Vir Biotechnology, Inc. (Director · Since at least Oct 10, 2019); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jan 2, 2025 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 11, 2019 · Past); BorgWarner Inc. (Director · Feb 12, 2014 – Apr 29, 2020 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2010 · Past); Bristol-Myers Squibb Company (Director · Jul 11, 2006 – Feb 1, 2021 · Past)
Director · May 2, 2006 – Feb 9, 2017 · Past
Jeffrey Capello
Other companies: Agios Pharmaceuticals, Inc. (Independent Director · Since at least Jun 13, 2023); Neogen Corporation (Director · Since at least Sep 2, 2022); Biogen Inc. (EVP & Chief Financial Officer · Dec 11, 2017 – Feb 12, 2020 · Past); Decoy Therapeutics Inc. (Director · Apr 1, 2015 – Jul 26, 2017 · Past); Tempest Therapeutics, Inc. (Director · Jun 11, 2012 – Jul 4, 2018 · Past); Boston Scientific Corporation (EVP & Chief Financial Officer · Jun 16, 2008 – Nov 27, 2013 · Past); Sirtris Pharmaceuticals Inc (Director · Jan 2, 2008 – Jan 2, 2008 · Past)
SVP & CFO · Jan 31, 2006 – Jan 29, 2008 · Past
Patrick J Sullivan
Other companies: Insulet Corporation (CEO and Chairman of the Board, Director · Sep 16, 2014 – Mar 29, 2018 · Past); Beacon Financial Corporation (EVP · Jul 21, 2011 – Jan 30, 2013 · Past); Legacy Bancorp Inc (President, Director · Apr 1, 2010 – Dec 31, 2010 · Past); Santander Holdings USA Inc (EVP & Mnging Dir. Comm. Bank · Jan 7, 2008 – Mar 3, 2008 · Past); Hologic Inc (Executive Chairman, Director · Oct 22, 2007 – May 28, 2008 · Past); Adeza Biomedical Corp (Director · Mar 19, 2007 – Mar 19, 2007 · Past); Cytyc Corp (Chief Executive Officer · Jan 24, 2006 – Oct 22, 2007 · Past)
Director · Feb 25, 2008 – Apr 30, 2019 · Past
Alexis P. Michas
Other companies: AstroNova, Inc. (Director · Since at least Jun 14, 2022); BorgWarner Inc. (Director · Since at least Feb 8, 2006); Allient Inc. (Director · May 6, 2015 – May 3, 2017 · Past); Airtran Holdings Inc (Director · May 24, 2006 – May 18, 2010 · Past); Lincoln Educational Services Corporation (Director · May 23, 2006 – May 1, 2015 · Past)
Managing Partner, Juniper Investment Company, LLC - Non-Executive Chair · Since at least May 2, 2006
Kevin Hrusovsky
Other companies: 908 Devices Inc. (Director · Since at least Dec 17, 2020); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 27, 2021 · Past); Quanterix Corporation (Executive Chairman, Director · Dec 6, 2017 – Jul 5, 2022 · Past); SeraCare Life Sciences Inc (Director · May 10, 2011 – Apr 20, 2012 · Past); Caliper Life Sciences Inc (President & CEO, Director · Mar 3, 2009 – Nov 7, 2011 · Past)
See Remarks · Feb 1, 2012 – May 31, 2013 · Past
Robert F. Friel
Other companies: West Pharmaceutical Services, Inc. (Director · Since at least Feb 17, 2020); Xylem Inc. (Chair, Xylem Inc. Former Chairman, President & CEO, PerkinElmer, Inc. · Since at least Dec 12, 2012); NuVasive Inc (Director · Feb 12, 2016 – Sep 1, 2023 · Past); CareFusion Corp (Director · Aug 31, 2009 – Mar 17, 2015 · Past); Millennium Pharmaceuticals Inc (Director · May 1, 2006 – May 14, 2008 · Past)
Chairman and CEO, Director · Jan 31, 2006 – Feb 13, 2019 · Past
Frank A. Wilson
Other companies: Novanta Inc. (Member of Board of Directors · Since at least May 13, 2021); Alkermes plc (Director · Since at least Sep 12, 2019); Cabot Corporation (Director · Since at least Sep 13, 2018); Sparton Corporation (Director · Mar 4, 2019 – Mar 4, 2019 · Past)
Please See Remarks · Dec 7, 2017 – Mar 5, 2018 · Past
Frank R. Witney
Other companies: Alamar Biosciences, Inc. (Director · Since at least Apr 16, 2026); Standard BioTools Inc. (Director · Since at least Jun 28, 2024); Cerus Corporation (Director · Since at least May 9, 2024); Telesis Bio, Inc. (Director · Jul 6, 2023 – Jul 6, 2023 · Past)
Director · Since at least May 1, 2024
John A. Roush
Other companies: Advanced Energy Industries, Inc. (Director · Since at least May 5, 2016); LeMaitre Vascular, Inc. (Director · Since at least Apr 9, 2014); ESS Tech, Inc. (Chief Financial Officer, Director · Sep 16, 2020 – Oct 8, 2021 · Past); Novanta Inc. (Chief Executive Officer, Director · Dec 14, 2010 – Sep 1, 2016 · Past)
Senior Vice President · Jan 31, 2006 – Feb 9, 2010 · Past
All 45 people
PersonSeat
Pascale Witz
Other companies: Regulus Therapeutics Inc (Director · Since at least Jun 1, 2017); Tesaro Inc (Director · May 10, 2018 – Jan 22, 2019 · Past); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past)
Director · Since at least Oct 27, 2017
Peter Barrett
Other companies: Obsidian Therapeutics, Inc. (Director · Since at least Aug 3, 2026); Synlogic Inc (Chairman, Partner, Atlas Venture · Since at least Jun 9, 2022); Larimar Therapeutics, Inc. (Director · May 10, 2022 – May 10, 2022 · Past)
Partner, Atlas Venture · Since at least May 6, 2022
Samuel R. Chapin
Other companies: PHINIA Inc. (Director · Since at least Jul 3, 2023); O-I Glass, Inc. (Director · Since at least May 12, 2021); CIRCOR International Inc (Director · Mar 17, 2021 – Oct 18, 2023 · Past)
Director · Since at least May 7, 2021
Sylvie Grégoire
Other companies: CervoMed Inc. (Co-Founder · Since at least Aug 16, 2023); Idm Pharma Inc (Director · Jun 14, 2006 – Jun 14, 2007 · Past); Cubist Pharmaceuticals Inc (Director · Jun 9, 2006 – Jun 10, 2010 · Past)
Director · Feb 6, 2015 – May 15, 2023 · Past
Daniel R Marshak
Other companies: InVivo Therapeutics Holdings Corp (Director · Sep 29, 2014 – Nov 17, 2022 · Past); Cambrex Corporation (Vice President · Jan 26, 2006 – Feb 27, 2006 · Past)
SVP & CSO · Apr 22, 2008 – Sep 26, 2014 · Past
Michael A. Klobuchar
Other companies: Eikon Therapeutics, Inc. (Chief Operating Officer · Since at least Feb 4, 2026); Merck & Company, Inc. (EVP - Chief Strategy Officer · Jul 5, 2021 – May 4, 2024 · Past)
Chief Operating Officer, Eikon Therapeutics, Inc. · Since at least Feb 1, 2024
Michel Vounatsos
Other companies: Zai Lab Ltd. (Director · Since at least Jan 7, 2023); Biogen Inc. (Director · Apr 18, 2016 – Nov 5, 2026 · Past)
Director · Since at least Mar 1, 2020
Sophie V. Vandebroek
Other companies: IDEXX Laboratories, Inc. (Director · Since at least Jul 15, 2013); Analogic Corporation (Director · Aug 1, 2008 – Feb 2, 2015 · Past)
Director · Since at least Feb 1, 2024
Frank Witney
Other companies: Cerus Corporation (Lead Independent Director · Since at least Mar 16, 2026)
Director · Since at least May 11, 2026
Michelle McMurry-Heath
Other companies: Bioventus Inc. (Director · Since at least Jan 1, 2022)
Founder and Chief Executive Officer, BioTechquity Clinical · Since at least Jul 22, 2022
Prahlad Singh
Other companies: Amphenol Corporation (Director · Since at least Jan 12, 2023)
President and Chief Executive Officer, Revvity · Since at least Oct 3, 2016
Tajinder Vohra
Other companies: Genpact Limited (Senior Vice President · Aug 1, 2007 – Feb 17, 2010 · Past)
Senior Vice President, Global Operations · Since at least Jan 29, 2018
Andrew OkunPlease See Remarks · Apr 26, 2011 – Apr 13, 2023 · Past
Anita GonzalesVP and CAO · Since at least May 13, 2023
Arvind Sundar-RajanSenior Vice President, Chief Digital & Strategy Officer · Since at least Nov 4, 2026
Bryan KippSenior Vice President, Technology and Licensing · Since at least Nov 10, 2025
Craig MonellSenior Vice President, Reagents · Since at least Aug 6, 2025
Daniel R TereauPlease See Remarks · Feb 1, 2016 – Feb 5, 2024 · Past
Deborah A ButtersPlease See Remarks · Jul 11, 2016 – Feb 7, 2020 · Past
Gabriel SchmergelDirector · Feb 15, 2006 – Feb 16, 2012 · Past
Gene LaySenior Vice President, Life Sciences and CEO Advisor · Since at least Nov 4, 2026
James CorbettPlease See Remarks · Feb 1, 2012 – Apr 30, 2019 · Past
Joel GoldbergSenior Vice President, Administration, General Counsel and Secretary · Since at least Jul 21, 2008
John R LetcherSee Remarks · Feb 1, 2010 – Jun 5, 2015 · Past
Katherine A OHaraSVP, Gen. Counsel, & Secretary · Jan 31, 2006 – Jan 29, 2008 · Past
Kevin QuickVice President of Platforms · Since at least Apr 16, 2026
Kevin WilloePresident, Revvity Signals Software · Since at least Oct 20, 2026
Madhuri HegdeSenior Vice President and Chief Scientific Officer · Since at least Oct 2, 2025
Magali FourSenior Vice President, Chief People and Culture Officer · Since at least Nov 4, 2026
Max KrakowiakSenior Vice President and Chief Financial Officer · Since at least Oct 2, 2026
Maxwell KrakowiakPlease See Remarks · Since at least Feb 5, 2024
Miriame VictorSenior Vice President and Chief Business Officer · Since at least Feb 5, 2024
Steve WilloughbyInvestor Relations · Since at least Oct 2, 2026
Yi-Ping LinSenior Vice President, Chief Quality, Regulatory and Clinical Officer · Since at least Nov 4, 2026
Yves DubaquieSenior Vice President, Diagnostics · Since at least Jun 2, 2025

Open People

Log in to ask 6ix AI your own questions about Revvity, Inc.